Low dose recombinant FSH treatment may reduce multiple gestations caused by controlled ovarian hyperstimulation and intrauterine insemination

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 111, Issue 11, 2004, Pages 1277-1282

  Papageorgiou, Theocharis C ^a,c   Guibert, Juliette ^a   Savale, Michèle ^a   Goffinet, François ^a   Fournier, Charles ^b   Merlet, Françoise ^a   Janssens, Yvette ^a   Zorn, Jean René ^a  

^a Hôpital Cochin ^*  (France)

^b CENTRE OSCAR LAMBRET   (France)

^c CENTRE HOSPITALIER RENÉ DUBOS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; RECOMBINANT FOLLITROPIN;

ADULT; ANOVULATION; ARTICLE; BIRTH RATE; DOSE RESPONSE; DOSE TIME EFFECT RELATION; ESTRADIOL BLOOD LEVEL; EVALUATION; FEMALE; GESTATIONAL AGE; HUMAN; INTRAUTERINE INSEMINATION; MAJOR CLINICAL STUDY; MULTIPLE PREGNANCY; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

ADULT; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INFERTILITY, FEMALE; INSEMINATION, ARTIFICIAL, HOMOLOGOUS; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PREGNANCY, MULTIPLE; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 8144222068     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2004.00439.x     Document Type: Article

References (33)

1. Trends in twin and triplet births: 1980-97. National Center for Health Statistics. Vital Health Stat 1999;47(24):1099-1120.
2. Strong Jr TH, Brar HS. Placenta previa in twin gestations. J Reprod Med 1989;34:415-416.
3. Wein P, Warwick MM, Beischer NA. Gestational diabetes in twin pregnancy: prevalence and long-term implications. Aust N Z J Obstet Gynaecol 1992;32:325-327.
4. Henderson CE, Scarpelli S, LaRosa D, Divon MY. Assessing the risk of gestational diabetes in twin gestation. J Natl Med Assoc 1995;87: 757-758.
5. Benirschke K. The biology of the twinning process: how placentation influences outcome. Semin Perinatol 1995;19:342-350.
6. Albrecht JL, Tomich PG. The maternal and neonatal outcome of triplet gestations. Am J Obstet Gynecol 1996;174:1551-1556.
7. Martin JA, MacDoramn MF, Mathews TJ. Triplet births: trends and outcomes 1971-94. Vital Health Stat 1997;21(55):1-20.
8. Adams DM, Sholl JS, Haney EI, Russell TL, Silver RK. Perinatal outcome associated with outpatient management of triplet pregnancy. Am J Obstet Gynecol 1998;178:843-847.
9. Callahan TL, Hall JE, Ettner SL, Christiansen CL, Greene MF, Crowley Jr WF. The economic impact of multiple-gestation pregnancies and the contribution of assisted-reproduction techniques to their incidence. N Engl J Med 1994;331:244-259.
10. Norwitz ER. Multiple pregnancy: trends past, present, and future. Infertil Reprod Med Clin North Am 1998;9:351-369.
11. The ESHRE Capri Workshop Group. Multiple gestation pregnancy. Hum Reprod 2000;15(7):1856-1864.
12. American Society for Reproductive Medicine. Multiple Pregnancy Associated with Infertility Therapy. A Practice Committee Report. An Educational Bulletin, 2000.
13. Nuojua-Huttunen S, Tomas C, Bloigu R, Tuomivaara L, Martikainen H. Intrauterine insemination treatment in subfertility: an analysis of factors affecting outcome. Hum Reprod 1999;14(3):698-703.
14. Guzick DS, Carson SA, Coutifaris C, et al. Efficacy of superovulation and intrauterine insemination in the treatment of infertility. N Engl J Med 1999;340(3):177-183.
15. Gleicher N, Oleske DM, Tur-Kaspa I, Vidali A, Karande V. Reducing the risk of high-order multiple pregnancy after ovarian stimulation with gonadotrophins. N Engl J Med 2000;343(1):2-7.
16. Khalil MR, Rasmussen PE, Erb K, Laursen SB, Rex S, Westergaard LG. Homologous intrauterine insemination. An evaluation of prognostic factors based on a review of 2473 cycles. Acta Obstet Gynecol Scand 2001;80:74-81.
17. Dickey RP, Taylor SN, Lu PY, Sartor BM, Rye PH, Pyrzak R. Relationship of follicle numbers and estradiol levels to multiple implantation in 3,608 intrauterine insemination cycles. Fertil Steril 2001;75(1):69-77.
18. Sagle MA, Hamilton-Fairley D, Kiddy DS, Franks S. A comparative, randomised study of low dose human menopausal gonadotrophin and follicle-stimulating hormone in women with polycystic ovarian syndrome. Fertil Steril 1991;55(1):56-60.
19. Balasch J, Ballesca JL, Pimentel C, Creus M, Fabregues F, Vanrell JA. Late low-dose pure follicle stimulating for ovarian stimulation in intra-uterine insemination cycles. Hum Reprod 1994;9(10):1863-1866.
20. Hughes EG, Collins JA, Gunby J. A randomized controlled trial of three low-dose gonadotrophin protocols for unexplained infertility. Hum Reprod 1998;13(6):1527-1531.
21. Goverde AJ, McDonnell J, Vermeiden JPW, Schals R, Rutten FFH, Schoemaker J. Intrauterine insemination or in-vitro fertilization in idiopathic sub-fertility and male sub-fertility: a randomized trial and cost-effectiveness analysis. Lancet 2000;355:13-18.
22. Pauerstein CJ, Eddy CA, Croxatto HD, Hess R, Siler-Khodr TM, Croxatto HB. Temporal relationships of estrogen, progesterone, and luteinizing hormone levels to ovulation in women and infrahuman primates. Am J Obstet Gynecol 1978;130:876-886.
23. Hughes EG. Ovarian stimulation plus intrauterine insemination for unexplained sub-fertility. 'Effective treatment' or 'not a natural choice'? Hum Reprod 2003;18:912-914.
24. Stone BA, Vargyas JM, Ringler GE, Stein AL, Marrs RP. Determinants of the outcome of intrauterine insemination: analysis of outcomes of 9963 consecutive cycles. Am J Obstet Gynecol 1999;180: 1522-1534.
25. Sahakyan M, Harlow BL, Hornstein MD. Influence of age, diagnosis, and cycle number on pregnancy rates with gonadotrophin-induced controlled ovarian hyperstimulation and intrauterine insemination. Fertil Steril 1999;72(3):500-504.
26. Pasqualotto EB, Falcone T, Goldberg JM, Petrauskis C, Nelson DR, Agarwal A. Risk factors for multiple gestation in women undergoing intrauterine insemination with ovarian stimulation. Fertil Steril 1999; 72(4):613-618.
27. Burr RW, Siegberg R, Flaherty SP, Wang XJ, Mathews CD. The influence of sperm morphology and the number of motile sperm inseminated on the outcome of intrauterine insemination combined with mild ovarian stimulation. Fertil Steril 1996;65:127-132.
28. Tomlinson MJ, Amissah-Artur JB, Thompson KA, Kasraie JL, Bentick B. Prognostic indicators for intrauterine insemination (IUI): statistical model for IUI success. Hum Reprod 1996;11:1892-1896.
29. Van Voorhis BI, Sparks AET, Allen BD, Stovall DW, Syrop CH. Cost-effectiveness of infertility treatments: a cohort study. Fertil Steril 1997;69:30-836.
30. Philips Z, Barazza Llorens M, Posnett J. Evaluation of the relative cost-effectiveness of treatments for infertility in the UK. Hum Reprod 2000;15:95-106.
31. Aboulghar M, Mansour R, Serour G, Abdrazek A, Amin Y, Rhodes C. Controlled ovarian stimulation and intrauterine insemination for treatment of unexplained infertility should be limited to a maximum of three trials. Fertil Steril 2001;75(1):88-91.
32. Schoolcraft WB, Gardner DK, Lane M, Schlenker T, Hamilton F, Meldrum DR. Blastocyst culture and transfer: analysis of results and parameters affecting outcome in two in vitro fertilization programs. Fertil Steril 1999;72(4):604-609.
33. Papageorgiou TC, Leondires MP, Miller BT, et al. Human chorionic gonadotrophin levels after blastocyst transfer are highly predictive of pregnancy outcome. Fertil Steril 2001;76(5):981-987.